Abstract:This review focuses key advances in different pediatric fields that were published in Italian Journal of Pediatrics and in international journals in 2015. Weaning studies continue to show promise for preventing food allergy. New diagnostic tools are available for identifying the allergic origin of allergic-like symptoms. Advances have been reported in obesity, short stature and autoimmune endocrine disorders. New molecules are offered to reduce weight gain and insulin-resistance in obese children. Regional investigations may provide suggestions for preventing short stature. Epidemiological studies have evidenced the high incidence of Graves' disease and Hashimoto's thyroiditis in patients with Down syndrome. Documentation of novel risk factors for celiac disease are of use to develop strategies for prevention in the population at-risk. Diagnostic criteria for non-celiac gluten sensitivity have been reported. Negative effect on nervous system development of the supernumerary X chromosome in Klinefelter syndrome has emerged. Improvements have been made in understanding rare diseases such as Rubinstein-Taybi syndrome. Eltrombopag is an effective therapy for immune trombocytopenia. Children with sickle-cell anemia are at risk for nocturnal enuresis. Invasive diseases caused by Streptococcus pyogenes are still common despite of vaccination. No difference in frequency of antibiotic prescriptions for acute otitis media between before the publication of the national guideline and after has been found. The importance of timing of iron administration in low birth weight infants, the effect of probiotics for preventing necrotising enterocolitis and perspectives for managing jaundice and cholestasis in neonates have been highlighted. New strategies have been developed to reduce the risk for relapse in nephrotic syndrome including prednisolone during upper respiratory infection. Insights into the pathophysiology of cerebral palsy, arterial ischemic stroke and acute encephalitis may drive advances in treatment. Recommendations on breastfeeding and complementary feeding have been updated. Novel treatments for rhabdomyosarcoma should be considered for paediatric patients. Control of risk factors for bronchiolitis and administration of pavilizumab for preventing respiratory syncytial virus infection may reduce hospitalization. Identification of risk factors for hospitalization in children with wheezing can improve the management of this disease. Deletions or mutations in genes encoding proteins for surfactant function may cause diffuse lung disease.

Pediatric Pulmonology 2023 year in review: Rare and diffuse lung disease

Pediatric pulmonology year in review 2023: Physiology

Pediatric pulmonology 2023 year in review: Asthma

Pediatric pulmonology year in review—Pediatric pulmonary critical care

Publishing Trends in World Journal of Pediatric Surgery

Recent advances in paediatric respiratory medicine

Clinical Study on Interstitial Lung Disease in Children of China

The changing landscape of pediatric lung transplantation

Childhood rare lung disease in the 21st century: "-omics" technology advances accelerating discovery

Pediatric Diffuse Lung Disease in Infants: Imaging Findings and Histopathologic Correlation

Innovations in the care of childhood interstitial lung disease associated with connective tissue disease and immune‐mediated disorders

Progress in pediatrics in 2015: choices in allergy, endocrinology, gastroenterology, genetics, haematology, infectious diseases, neonatology, nephrology, neurology, nutrition, oncology and pulmonology

Advances for pediatricians in 2022: allergy, anesthesiology, cardiology, dermatology, endocrinology, gastroenterology, genetics, global health, infectious diseases, metabolism, neonatology, neurology, oncology, pulmonology

Advances in pediatrics in 2023: choices in allergy, analgesia, cardiology, endocrinology, gastroenterology, genetics, global health, hematology, infectious diseases, neonatology, neurology, pulmonology

Year in Review 2014: Interstitial Lung Disease, Physiology, Sleep and Ventilation, Acute Respiratory Distress Syndrome, Cystic Fibrosis, Bronchiectasis and Rare Lung Disease

Pulmonary fibrosis may begin in infancy: from childhood to adult interstitial lung disease

Clinical scope and healthcare utilization in childhood interstitial lung disease at a tertiary center

Severe pediatric COVID-19: a review from the clinical and immunopathophysiological perspectives

Approach to the patient with Childhood Interstitial and Diffuse Lung Disease

An interdisciplinary consensus approach to pulmonary hypertension in developmental lung disease

Epidemiology of childhood interstitial lung disease in France: the RespiRare cohort